Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Mayo Clin Proc ; 98(3): 451-457, 2023 03.
Artigo em Inglês | MEDLINE | ID: mdl-36868753

RESUMO

There is scant information on the clinical progression, end-of-life decisions, and cause of death of patients with cancer diagnosed with COVID-19. Therefore, we conducted a case series of patients admitted to a comprehensive cancer center who did not survive their hospitalization. To determine the cause of death, 3 board-certified intensivists reviewed the electronic medical records. Concordance regarding cause of death was calculated. Discrepancies were resolved through a joint case-by-case review and discussion among the 3 reviewers. During the study period, 551 patients with cancer and COVID-19 were admitted to a dedicated specialty unit; among them, 61 (11.6%) were nonsurvivors. Among nonsurvivors, 31 (51%) patients had hematologic cancers, and 29 (48%) had undergone cancer-directed chemotherapy within 3 months before admission. The median time to death was 15 days (95% confidence interval [CI], 11.8 to 18.2). There were no differences in time to death by cancer category or cancer treatment intent. The majority of decedents (84%) had full code status at admission; however, 53 (87%) had do-not-resuscitate orders at the time of death. Most deaths were deemed to be COVID-19 related (88.5%). The concordance between the reviewers for the cause of death was 78.7%. In contrast to the belief that COVID-19 decedents die because of their comorbidities, in our study only 1 of every 10 patients died of cancer-related causes. Full-scale interventions were offered to all patients irrespective of oncologic treatment intent. However, most decedents in this population preferred care with nonresuscitative measures rather than full support at the end of life.


Assuntos
COVID-19 , Neoplasias Hematológicas , Neoplasias , Humanos , Causas de Morte , Oncologia
2.
Clin J Oncol Nurs ; 22(4): 453-456, 2018 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-30035782

RESUMO

Respiratory depression is a complication that often follows cancer-related surgery and can result in life-threatening consequences. Oncology nurses caring for postoperative patients must monitor for respiratory complications and implement measures to prevent respiratory depression. A review of postoperative respiratory depression risk factors, clinical findings, and monitoring will be presented in this article using a case study.


Assuntos
Neoplasias/complicações , Neoplasias/cirurgia , Enfermagem Oncológica/métodos , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/enfermagem , Insuficiência Respiratória/etiologia , Insuficiência Respiratória/enfermagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Monitorização Fisiológica/métodos , Estudos Retrospectivos , Fatores de Risco , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA